-+ 0.00%
-+ 0.00%
-+ 0.00%

Sandoz Begins Sale of Semaglutide for Injection in Brazil

MT Newswires·11/09/2026 01:18:07
Listen to the news
01:18 AM EST, 11/09/2026 (MT Newswires) -- Sandoz Group (SDZ.SW) launched semaglutide solution for injection in Brazil under the Owozy brand, according to a Monday release. Developed by pharmaceutical company Adalvo, the treatment option for type 2 diabetes received approval from the Brazilian Health Regulatory Agency on July 29. The Switzerland-listed drugmaker sought the assistance of Biolab & Co. for the commercialization and distribution of the treatment in Brazil.